1. Home
  2. MCHX vs OKYO Comparison

MCHX vs OKYO Comparison

Compare MCHX & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marchex Inc. Class B

MCHX

Marchex Inc. Class B

N/A

Current Price

$1.63

Market Cap

70.3M

ML Signal

N/A

Logo OKYO Pharma Limited

OKYO

OKYO Pharma Limited

HOLD

Current Price

$2.06

Market Cap

79.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCHX
OKYO
Founded
2003
2007
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
70.3M
79.7M
IPO Year
2004
2022

Fundamental Metrics

Financial Performance
Metric
MCHX
OKYO
Price
$1.63
$2.06
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$6.00
AVG Volume (30 Days)
33.8K
180.6K
Earning Date
11-13-2025
07-18-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$46,494,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$6.70
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.26
$0.90
52 Week High
$2.40
$3.35

Technical Indicators

Market Signals
Indicator
MCHX
OKYO
Relative Strength Index (RSI) 48.29 48.62
Support Level $1.60 $1.90
Resistance Level $1.70 $2.40
Average True Range (ATR) 0.08 0.20
MACD 0.01 0.03
Stochastic Oscillator 66.67 50.72

Price Performance

Historical Comparison
MCHX
OKYO

About MCHX Marchex Inc. Class B

Marchex Inc harnesses the power of AI and conversational intelligence to provide actionable insights aligned with prescriptive vertical market data analytics, driving operational excellence and revenue acceleration. Marchex enables executive, sales, and marketing teams to optimize customer journey experiences across communications channels, enabling enterprise strategies, empowering businesses to increase revenue through informed decision-making and strategic execution.

About OKYO OKYO Pharma Limited

OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.

Share on Social Networks: